CytoDyn (CYDY) Other Accumulated Expenses (2009 - 2026)
CytoDyn (CYDY) recorded Other Accumulated Expenses of $11.6 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with $45,000 a year earlier and down 24.4% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended May 31, 2026), CytoDyn reported Other Accumulated Expenses of $15.35 million.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of 6.9% (FY2021 to FY2026).
- Across earlier fiscal years, Other Accumulated Expenses came in at $145,000 in FY2025 (+480.0%), $25,000 in FY2024 (-85.1%), $168,000 in FY2023 (-91.6%) and $2.01 million in FY2022 (-81.8%).
- Quarterly Other Accumulated Expenses has ranged from $25,000 in fiscal Q4 2024 to $15.4 million in fiscal Q2 2026 over the past five years.
- On a year-over-year basis, Other Accumulated Expenses rose in three of the last four quarters, with growth averaging 141.6%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 480.0% in fiscal Q4 2025, against a decline of 95.5% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $15.35 million (Q4 2026), $12.75 million (Q3 2026) and $15.4 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 11.60 Mn |
| May 31, 2026 | 15.35 Mn |
| Feb 28, 2026 | 12.75 Mn |
| Nov 30, 2025 | 15.40 Mn |
| Aug 31, 2025 | 45,000.00 |
| May 31, 2025 | 145,000.00 |
| Feb 28, 2025 | 201,000.00 |
| Nov 30, 2024 | 142,000.00 |
| Aug 31, 2024 | 142,000.00 |
| May 31, 2024 | 25,000.00 |
| Feb 29, 2024 | 112,000.00 |
| Nov 30, 2023 | 81,000.00 |
| Aug 31, 2023 | 239,000.00 |
| May 31, 2023 | 168,000.00 |
| Feb 28, 2023 | 1.21 Mn |
| Nov 30, 2022 | 200,000.00 |
| Aug 31, 2022 | 1.02 Mn |
| May 31, 2022 | 2.01 Mn |
| Feb 28, 2022 | 4.52 Mn |
| Nov 30, 2021 | 4.46 Mn |
API Access
CytoDyn Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();